Loading JAN detail
Loading ticker data...
Loading JAN detail
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction.
Its lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
Chart data unavailable
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN), a pure-play senior housing real estate investment trust (REIT), is scheduled to report first quarter 2026 financial results after the close of trading on the New York Stock Exchange on Tuesday, May 5, 2026. Janus Living will host a conference call and webcast on Wednesday, May 6, 2026 at 12:00 p.m. Eastern Time to review its financial performance and operating results. The conference call can be accessed in the following ways: Janus Livin.
JAN (NYSE: JAN - Get Free Report) Director John Arabia acquired 60,000 shares of the firm's stock in a transaction dated Monday, March 23rd. The stock was bought at an average price of $20.00 per share, for a total transaction of $1,200,000.00. Following the acquisition, the director owned 67,500 shares of the company's stock, valued at
Janus Living debuted as the only U.S. REIT focused exclusively on senior housing, operating under a unique RIDEA structure. JAN's portfolio spans 34 communities, heavily concentrated in Texas and Florida, with 85% occupancy and $771 million in 2025 revenues. At a $24 share price, Janus trades at a demanding 25x adjusted FFO, with a reduced 2.4% dividend yield post-IPO.
REITs were rolling out of the gates in early-2026, coming back into favor amid a HALO trade (Heavy Assets, Low Obsolescence) after a half-decade of rate headwinds and unfavorable narrative. The oil price surge tied to the Iran conflict has complicated the rotation by sending rates soaring, yet REITs have remained surprisingly resilient in recent weeks, maintaining sizable year-to-date outperformance. REIT-rate correlations have eased in recent quarters, signaling a more favorable "regime change" where performance is driven by property fundamentals rather than macro forces, following a prolonged period of rate-dominated.
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced today that it has closed on a new $500 million unsecured revolving credit facility (the “Revolving Facility”) and a $100 million unsecured delayed-draw term loan facility (the “Term Loan”, and together with the Revolving Facility, the “Credit Facility”). The Revolving Facility provides for borrowing up to $500 million and matures in March 2030, with.
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (NYSE: JAN) (“Janus Living”) announced today that Janus Living has completed its initial public offering of 48,300,000 shares of its Class A-1 common stock, which includes the exercise in full by the underwriters of their option to purchase up to an additional 6,300,000 shares of Class A-1 common stock, at a price to the public of $20.00 per share. Shares of Janus Living's Class A-1 common sto.
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 20, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.
